Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Cali, Valle del Cauca Department, Colombia, 760032 as a study location. Removed Santiago de Cali, Valle del Cauca Department, Colombia, 760032 as a study location.
    Difference
    0.2%
    Check dated 2025-10-30T09:20:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.
    Difference
    0.0%
    Check dated 2025-10-01T02:37:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a software or content version increment with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-30T02:52:50.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; 'Back to Top' link/button removed. No changes to core content or time-sensitive data.
    Difference
    0.1%
    Check dated 2025-09-15T19:26:21.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-08T15:07:34.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing several previously listed locations. Notably, the names of drugs such as lenvatinib and pembrolizumab have been retained, indicating a focus on medical content.
    Difference
    21%
    Check dated 2025-09-01T09:39:22.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.